Hyderabad Telangana, India

Venugopala Chokkasandra Jayaramareddy

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Aurobindo Pharma Limited. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venugopala Chokkasandra Jayaramareddy. Retrieved from https://idiyas.com/inventor/venugopala-chokkasandra-jayaramareddy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Venugopala Chokkasandra Jayaramareddy: Innovator in Pharmaceutical Compositions

Introduction

Venugopala Chokkasandra Jayaramareddy is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidiabetic agents. His work has led to advancements that benefit patients in need of effective treatments.

Latest Patents

Venugopala holds 1 patent for his invention titled "Pharmaceutical compositions of linagliptin and process for preparation thereof." This patent focuses on pharmaceutical compositions that include linagliptin or its pharmaceutically acceptable salts as active agents. The invention also details the process for preparing these compositions and methods for administering them to subjects requiring treatment.

Career Highlights

He is currently associated with Aurobindo Pharma Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to leverage his expertise in developing innovative solutions for healthcare challenges.

Collaborations

Some of his coworkers include Sreenivas Reddy and Chandrashekhar Shriram Kandi, who contribute to the collaborative environment at Aurobindo Pharma Limited.

Conclusion

Venugopala Chokkasandra Jayaramareddy's work in pharmaceutical compositions exemplifies the impact of innovation in healthcare. His contributions continue to pave the way for advancements in the treatment of diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…